Sienna Biopharmaceuticals' IPO

Sienna Biopharmaceuticals raised a round of funding on July 27, 2017. Investors include Public.

Sienna Biopharmaceuticals (NASDAQ: SNNA) is a medical dermatology and aesthetics company focused on developing safe and effective targeted therapies to treat inflammatory skin conditions and aesthetic…

Articles about Sienna Biopharmaceuticals' IPO: